nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS2—urinary bladder cancer	0.599	1	CbGaD
Lornoxicam—PTGS2—Cisplatin—urinary bladder cancer	0.0954	0.282	CbGbCtD
Lornoxicam—PTGS2—Etoposide—urinary bladder cancer	0.0938	0.277	CbGbCtD
Lornoxicam—PTGS1—Etoposide—urinary bladder cancer	0.0792	0.234	CbGbCtD
Lornoxicam—CYP2C9—Fluorouracil—urinary bladder cancer	0.0382	0.113	CbGbCtD
Lornoxicam—CYP2C9—Cisplatin—urinary bladder cancer	0.0324	0.0957	CbGbCtD
Lornoxicam—CYP2C9—urine—urinary bladder cancer	0.00195	0.207	CbGeAlD
Lornoxicam—Tenoxicam—PTGS2—urinary bladder cancer	0.00186	0.429	CrCbGaD
Lornoxicam—Meloxicam—PTGS2—urinary bladder cancer	0.00132	0.306	CrCbGaD
Lornoxicam—Piroxicam—PTGS2—urinary bladder cancer	0.00115	0.265	CrCbGaD
Lornoxicam—PTGS1—prostate gland—urinary bladder cancer	0.000639	0.068	CbGeAlD
Lornoxicam—PTGS2—prostate gland—urinary bladder cancer	0.000611	0.065	CbGeAlD
Lornoxicam—PTGS1—Biological oxidations—GSTO2—urinary bladder cancer	0.000551	0.0115	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—NAT1—urinary bladder cancer	0.000551	0.0115	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000551	0.0115	CbGpPWpGaD
Lornoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000547	0.0114	CbGpPWpGaD
Lornoxicam—PTGS1—seminal vesicle—urinary bladder cancer	0.000541	0.0575	CbGeAlD
Lornoxicam—PTGS2—seminal vesicle—urinary bladder cancer	0.000517	0.055	CbGeAlD
Lornoxicam—PTGS2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000515	0.0108	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—UGT2B7—urinary bladder cancer	0.000504	0.0105	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—PTGS2—urinary bladder cancer	0.00049	0.0102	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.000475	0.00993	CbGpPWpGaD
Lornoxicam—PTGS1—epithelium—urinary bladder cancer	0.00047	0.0499	CbGeAlD
Lornoxicam—PTGS1—Biological oxidations—CYP4B1—urinary bladder cancer	0.000454	0.00948	CbGpPWpGaD
Lornoxicam—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000453	0.0481	CbGeAlD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000449	0.00938	CbGpPWpGaD
Lornoxicam—PTGS2—epithelium—urinary bladder cancer	0.000449	0.0477	CbGeAlD
Lornoxicam—CYP2C9—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000448	0.00935	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000444	0.00927	CbGpPWpGaD
Lornoxicam—PTGS1—renal system—urinary bladder cancer	0.000436	0.0463	CbGeAlD
Lornoxicam—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000433	0.046	CbGeAlD
Lornoxicam—PTGS2—S1P1 pathway—RHOA—urinary bladder cancer	0.00043	0.00898	CbGpPWpGaD
Lornoxicam—PTGS2—renal system—urinary bladder cancer	0.000417	0.0443	CbGeAlD
Lornoxicam—PTGS2—urethra—urinary bladder cancer	0.000409	0.0435	CbGeAlD
Lornoxicam—PTGS1—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000408	0.00852	CbGpPWpGaD
Lornoxicam—PTGS1—Eicosanoid Synthesis—PTGS2—urinary bladder cancer	0.000406	0.00849	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—BIRC3—urinary bladder cancer	0.000393	0.0082	CbGpPWpGaD
Lornoxicam—PTGS1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000384	0.00802	CbGpPWpGaD
Lornoxicam—CYP2C9—female reproductive system—urinary bladder cancer	0.000382	0.0406	CbGeAlD
Lornoxicam—PTGS2—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.000377	0.00788	CbGpPWpGaD
Lornoxicam—PTGS1—female reproductive system—urinary bladder cancer	0.000349	0.0371	CbGeAlD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000341	0.00712	CbGpPWpGaD
Lornoxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—urinary bladder cancer	0.00034	0.0071	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—MPO—urinary bladder cancer	0.000336	0.00702	CbGpPWpGaD
Lornoxicam—PTGS2—female reproductive system—urinary bladder cancer	0.000334	0.0355	CbGeAlD
Lornoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—urinary bladder cancer	0.000332	0.00695	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000331	0.00691	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000324	0.00676	CbGpPWpGaD
Lornoxicam—PTGS1—vagina—urinary bladder cancer	0.000316	0.0336	CbGeAlD
Lornoxicam—CYP2C9—Biological oxidations—GSTZ1—urinary bladder cancer	0.000306	0.00639	CbGpPWpGaD
Lornoxicam—PTGS2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000305	0.00637	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—NAT2—urinary bladder cancer	0.000302	0.00631	CbGpPWpGaD
Lornoxicam—PTGS2—vagina—urinary bladder cancer	0.000302	0.0321	CbGeAlD
Lornoxicam—CYP2C9—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000301	0.0063	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—GSTO2—urinary bladder cancer	0.00029	0.00605	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—NAT1—urinary bladder cancer	0.00029	0.00605	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000286	0.00597	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000267	0.00558	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—UGT2B7—urinary bladder cancer	0.000265	0.00554	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000263	0.00549	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000261	0.00546	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—urinary bladder cancer	0.000257	0.00537	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000256	0.00535	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—urinary bladder cancer	0.000251	0.00524	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000244	0.0051	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—HPGDS—urinary bladder cancer	0.000241	0.00504	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—CYP4B1—urinary bladder cancer	0.000239	0.00499	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000235	0.00492	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—GSTT1—urinary bladder cancer	0.000234	0.00489	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000233	0.00487	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000231	0.00483	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—urinary bladder cancer	0.000228	0.00476	CbGpPWpGaD
Lornoxicam—PTGS1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000226	0.00472	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000225	0.00471	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.00021	0.00439	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.00021	0.00439	CbGpPWpGaD
Lornoxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000206	0.00429	CbGpPWpGaD
Lornoxicam—PTGS1—lymph node—urinary bladder cancer	0.000204	0.0217	CbGeAlD
Lornoxicam—PTGS2—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000203	0.00424	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000202	0.00422	CbGpPWpGaD
Lornoxicam—PTGS2—lymph node—urinary bladder cancer	0.000195	0.0207	CbGeAlD
Lornoxicam—PTGS2—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000194	0.00405	CbGpPWpGaD
Lornoxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	0.000181	0.00377	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000179	0.00374	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000176	0.00368	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000175	0.00366	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000174	0.00364	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—urinary bladder cancer	0.000174	0.00363	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000168	0.0035	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—urinary bladder cancer	0.000166	0.00347	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—GSTP1—urinary bladder cancer	0.000162	0.00339	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000159	0.00333	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000159	0.00332	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000157	0.00327	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000155	0.00324	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—GSTM1—urinary bladder cancer	0.000149	0.00312	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.000145	0.00302	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000144	0.003	CbGpPWpGaD
Lornoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.000142	0.00297	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000141	0.00295	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000139	0.0029	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000138	0.00289	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000136	0.00284	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000129	0.0027	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000128	0.00268	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.000127	0.00265	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	0.000127	0.00265	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	0.000126	0.00264	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000123	0.00257	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	0.000121	0.00253	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000119	0.00248	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000112	0.00234	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.00011	0.0023	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	0.00011	0.00229	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000109	0.00228	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	0.000107	0.00224	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	0.000104	0.00216	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	9.97e-05	0.00208	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	9.94e-05	0.00208	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	9.85e-05	0.00206	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	9.76e-05	0.00204	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	9.71e-05	0.00203	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTO2—urinary bladder cancer	9.43e-05	0.00197	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NAT1—urinary bladder cancer	9.43e-05	0.00197	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.27e-05	0.00194	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	9.16e-05	0.00191	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—GSTO2—urinary bladder cancer	8.94e-05	0.00187	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	8.75e-05	0.00183	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	8.63e-05	0.0018	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	8.62e-05	0.0018	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	8.59e-05	0.00179	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	8.58e-05	0.00179	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	8.55e-05	0.00179	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	8.53e-05	0.00178	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.42e-05	0.00176	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	8.37e-05	0.00175	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	8.15e-05	0.0017	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	7.93e-05	0.00166	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	7.92e-05	0.00165	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	7.89e-05	0.00165	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	7.84e-05	0.00164	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	7.76e-05	0.00162	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.73e-05	0.00162	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	7.7e-05	0.00161	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	7.5e-05	0.00157	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTO2—urinary bladder cancer	7.48e-05	0.00156	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NAT1—urinary bladder cancer	7.48e-05	0.00156	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	7.4e-05	0.00155	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.36e-05	0.00154	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	7.33e-05	0.00153	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PRSS3—urinary bladder cancer	7.14e-05	0.00149	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC19A1—urinary bladder cancer	6.95e-05	0.00145	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	6.84e-05	0.00143	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PRSS3—urinary bladder cancer	6.77e-05	0.00141	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	6.74e-05	0.00141	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	6.54e-05	0.00137	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HDAC4—urinary bladder cancer	6.46e-05	0.00135	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	6.4e-05	0.00134	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	6.28e-05	0.00131	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	6.16e-05	0.00129	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	6.09e-05	0.00127	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	5.82e-05	0.00122	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.73e-05	0.0012	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—TYMP—urinary bladder cancer	5.71e-05	0.00119	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PRSS3—urinary bladder cancer	5.67e-05	0.00118	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	5.55e-05	0.00116	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.49e-05	0.00115	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	5.37e-05	0.00112	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	5.37e-05	0.00112	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	5.35e-05	0.00112	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	5.23e-05	0.00109	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NAT2—urinary bladder cancer	5.17e-05	0.00108	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—LIG1—urinary bladder cancer	5.13e-05	0.00107	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	5.11e-05	0.00107	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.97e-05	0.00104	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NAT1—urinary bladder cancer	4.96e-05	0.00104	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	4.96e-05	0.00104	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.87e-05	0.00102	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.55e-05	0.00095	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TYMP—urinary bladder cancer	4.53e-05	0.000947	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	4.53e-05	0.000947	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—RRM2—urinary bladder cancer	4.46e-05	0.000931	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.45e-05	0.000929	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.35e-05	0.00091	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.35e-05	0.000909	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	4.14e-05	0.000866	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ENO2—urinary bladder cancer	4.13e-05	0.000863	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—HPGDS—urinary bladder cancer	4.13e-05	0.000863	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	4.11e-05	0.000859	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.11e-05	0.000858	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NAT2—urinary bladder cancer	4.1e-05	0.000857	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	4.08e-05	0.000853	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTT1—urinary bladder cancer	4.01e-05	0.000837	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.94e-05	0.000824	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ENO2—urinary bladder cancer	3.91e-05	0.000818	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.85e-05	0.000805	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.76e-05	0.000785	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RBX1—urinary bladder cancer	3.71e-05	0.000775	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.65e-05	0.000763	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—RRM2—urinary bladder cancer	3.54e-05	0.000739	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NQO1—urinary bladder cancer	3.33e-05	0.000695	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—JAG1—urinary bladder cancer	3.32e-05	0.000694	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ENO2—urinary bladder cancer	3.28e-05	0.000685	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HPGDS—urinary bladder cancer	3.28e-05	0.000685	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.26e-05	0.000681	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.23e-05	0.000675	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTT1—urinary bladder cancer	3.18e-05	0.000664	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.13e-05	0.000654	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.01e-05	0.000629	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TYMP—urinary bladder cancer	3e-05	0.000627	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.88e-05	0.000602	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.82e-05	0.000588	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTP1—urinary bladder cancer	2.78e-05	0.00058	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.72e-05	0.000567	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.69e-05	0.000561	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NQO1—urinary bladder cancer	2.64e-05	0.000552	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—TYMS—urinary bladder cancer	2.58e-05	0.000539	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTM1—urinary bladder cancer	2.55e-05	0.000533	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NCOR1—urinary bladder cancer	2.55e-05	0.000533	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GPX1—urinary bladder cancer	2.44e-05	0.00051	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NCOR1—urinary bladder cancer	2.42e-05	0.000505	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ERCC2—urinary bladder cancer	2.4e-05	0.000501	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.34e-05	0.00049	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ERCC2—urinary bladder cancer	2.27e-05	0.000475	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MTHFR—urinary bladder cancer	2.25e-05	0.000471	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.24e-05	0.000467	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTP1—urinary bladder cancer	2.2e-05	0.00046	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.17e-05	0.000453	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.17e-05	0.000453	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.16e-05	0.000451	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTHFR—urinary bladder cancer	2.14e-05	0.000446	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.13e-05	0.000445	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TERT—urinary bladder cancer	2.13e-05	0.000445	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.11e-05	0.00044	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.07e-05	0.000433	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TYMS—urinary bladder cancer	2.05e-05	0.000428	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTM1—urinary bladder cancer	2.03e-05	0.000423	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NCOR1—urinary bladder cancer	2.03e-05	0.000423	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGFR3—urinary bladder cancer	1.96e-05	0.000409	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.94e-05	0.000405	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.9e-05	0.000398	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.83e-05	0.000382	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.79e-05	0.000374	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.76e-05	0.000367	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.75e-05	0.000366	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.7e-05	0.000355	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CREBBP—urinary bladder cancer	1.66e-05	0.000348	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RHOA—urinary bladder cancer	1.51e-05	0.000315	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.48e-05	0.000309	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.46e-05	0.000305	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PPARG—urinary bladder cancer	1.45e-05	0.000303	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.44e-05	0.0003	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.41e-05	0.000295	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CREBBP—urinary bladder cancer	1.39e-05	0.000291	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ERBB2—urinary bladder cancer	1.39e-05	0.000291	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.36e-05	0.000283	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.34e-05	0.00028	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.34e-05	0.00028	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.28e-05	0.000268	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.26e-05	0.000263	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.25e-05	0.000262	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—EP300—urinary bladder cancer	1.2e-05	0.00025	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CDKN1A—urinary bladder cancer	1.19e-05	0.000249	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PTEN—urinary bladder cancer	1.19e-05	0.000248	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.19e-05	0.000248	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EP300—urinary bladder cancer	1.13e-05	0.000237	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SRC—urinary bladder cancer	1.1e-05	0.00023	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PTEN—urinary bladder cancer	9.96e-06	0.000208	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MYC—urinary bladder cancer	9.88e-06	0.000206	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EGFR—urinary bladder cancer	9.66e-06	0.000202	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PPARG—urinary bladder cancer	9.61e-06	0.000201	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—EP300—urinary bladder cancer	9.5e-06	0.000198	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	9.23e-06	0.000193	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—KRAS—urinary bladder cancer	9.13e-06	0.000191	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HRAS—urinary bladder cancer	7.76e-06	0.000162	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	7.56e-06	0.000158	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTEN—urinary bladder cancer	6.59e-06	0.000138	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—EP300—urinary bladder cancer	6.29e-06	0.000131	CbGpPWpGaD
